The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ZURA FINANCIAL STATEMENTS

Zura Bio Limited Class A Ordinary Shares — balance sheet, income statement and cash flow trends

ZURAZura Bio Limited Class A Ordinary Shares

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-45 K $ · -Infinity%Operating Income-92.8 M $ · -Infinity%Pre-tax Income-85.8 M $ · -Infinity%Net Income to Owners-85.7 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-45 K $—
Operating Income-92.8 M $—
EBITDA-85.7 M $—
Net Income to Owners-85.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets213.4 M
  • Equity197.1 M $92%
  • Current Liabilities16.3 M $8%

Key Figures

YoY change
Total Assets213.4 M $+35.2%
Total Liabilities16.3 M $-12.7%
Total Equity197.1 M $+56.5%
Cash & ST Investments205.1 M $+32.8%
Total Debt——
Net Debt-205.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M050 M-77.5 M $Operating-86 K $Investing128.3 M $Financing50.6 M $Net Change

Key Figures

YoY change
Operating Cash Flow-77.5 M $—
Capital Expenditures86 K $-29.5%
Free Cash Flow-77.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ZURA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.